Project details
German autoimmune disease IVD company seeks investment.
| Project region | Germany |
|---|---|
| Industry | Healthcare |
| Total value of the target | N/A |
| Expected target net rate of return after deducting all taxes and fees | N/A |
| Validity period of pending order | 365 |
CONTACT ADVISOR
| Project highlights | To be confirmed |
|---|---|
| Project description |
The company mainly develops and produces autoimmune disease diagnostic reagent products for early detection, diagnosis and prediction of autoimmune diseases. At present, the company has introduced more than 150 products in the field of diagnostic reagents. Main diagnostics include rheumatology, thrombosis, gastroenterology, vasculitis, thyroid, diabetes, liver disease and lyme disease ELISA detection, immunofluorescence based on cell and tissue slides, and IFA. With more than 200 employees in 20 countries and sales in more than 90 countries. |
We provide expert advisory and corporate services across Asia, guiding businesses through complex markets and regulations.
Have Any Questions?
Reach out to our local experts, we’ll respond within one business day.
Our Clients
Discover our esteemed global clients across diverse sectors. We believe in providing our clients with exceptional service and a commitment to being their partner for growth in Asia.
See what our clients say about us
